Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 134,106
  • Shares Outstanding, K 47,895
  • Annual Sales, $ 76,020 K
  • Annual Income, $ -28,520 K
  • 60-Month Beta 0.91
  • Price/Sales 1.73
  • Price/Cash Flow N/A
  • Price/Book 2.23
Trade ENZ with:

Options Overview

Details
  • Implied Volatility 94.53%
  • Historical Volatility 52.42%
  • IV Percentile 18%
  • IV Rank 5.07%
  • IV High 725.17% on 04/07/20
  • IV Low 60.85% on 12/16/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 435
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 2,366
  • Open Int (30-Day) 4,553

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.61 +5.75%
on 03/05/21
3.59 -23.12%
on 02/16/21
-0.68 (-19.77%)
since 02/08/21
3-Month
2.22 +24.32%
on 12/28/20
3.59 -23.12%
on 02/16/21
+0.35 (+14.52%)
since 12/08/20
52-Week
1.56 +76.92%
on 03/18/20
4.85 -43.09%
on 03/09/20
-0.64 (-18.82%)
since 03/06/20

Most Recent Stories

More News
Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced that the Company will present at H.C. Wainwright Global Life Sciences Conference,...

ENZ : 2.76 (-1.43%)
Enzo Announces its GENFLEX(TM) Molecular Test Detects Current COVID-19 Variants

Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results

ENZ : 2.76 (-1.43%)
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, announced today that it will report second quarter 2021 financial results on Monday, March 15, 2021,...

ENZ : 2.76 (-1.43%)
Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc. - February 26, 2021

EQNX::TICKER_START EQNX::TICKER_END

ENZ : 2.76 (-1.43%)
180 Degree Capital Corp. Issues Open Letter to the Board and Shareholders of Enzo Biochem, Inc.

180 Degree Capital Corp. (NASDAQ:TURN) ("180" and the "Company"), today issued the following open letter to the board and shareholders of Enzo Biochem, Inc. ("ENZ").

ENZ : 2.76 (-1.43%)
TURN : 7.22 (+0.84%)
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,899,827 entitled "Antibodies Specific for...

ENZ : 2.76 (-1.43%)
ENZO BIOCHEM'S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced that the Enzo Board of Directors has formed two new committees to support strategy...

ENZ : 2.76 (-1.43%)
Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.

, /PRNewswire/ -- Roumell Asset Management, LLC ("Roumell"), which owns 5.78% of the outstanding shares of common stock (the "Common Stock") of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or "the Company"),...

ENZ : 2.76 (-1.43%)
ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT

Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or "The Company"), a leading biosciences and diagnostics company, today announced that it will participate in the 10 Annual LifeSci Partners Corporate Access Event,...

ENZ : 2.76 (-1.43%)
Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc.

EQNX::TICKER_START EQNX::TICKER_END

ENZ : 2.76 (-1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

3rd Resistance Point 2.92
2nd Resistance Point 2.87
1st Resistance Point 2.82
Last Price 2.76
1st Support Level 2.72
2nd Support Level 2.67
3rd Support Level 2.62

See More

52-Week High 4.85
Fibonacci 61.8% 3.59
Fibonacci 50% 3.20
Fibonacci 38.2% 2.82
Last Price 2.76
52-Week Low 1.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar